Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Goodwill & Intangibles (2017 - 2026)

Organogenesis Holdings has reported Goodwill & Intangibles over the past 9 years, most recently at $37.9 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 8.06% year-over-year to $37.9 million; the TTM value through Dec 2025 reached $37.9 million, down 8.06%, while the annual FY2025 figure was $37.9 million, 8.06% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $37.9 million at Organogenesis Holdings, down from $38.7 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $58.2 million in Q1 2021 and troughed at $37.9 million in Q4 2025.
  • A 5-year average of $47.2 million and a median of $46.5 million in 2023 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: grew 27.75% in 2021 and later dropped 9.92% in 2023.
  • Year by year, Goodwill & Intangibles stood at $54.4 million in 2021, then fell by 8.97% to $49.6 million in 2022, then dropped by 9.92% to $44.6 million in 2023, then decreased by 7.62% to $41.2 million in 2024, then fell by 8.06% to $37.9 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for ORGO at $37.9 million in Q4 2025, $38.7 million in Q3 2025, and $39.6 million in Q2 2025.